ID   RB1021
AC   CVCL_S624
SY   RB 1021
DR   Wikidata; Q54949275
RX   PubMed=11520568;
RX   PubMed=15326157;
RX   PubMed=18036396;
RX   PubMed=19686387;
RX   PubMed=23498719;
RX   PubMed=27115612;
RX   PubMed=32123578;
CC   Miscellaneous: STR profile from personal communication of Bremner, Rod.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 13
ST   D16S539: 13
ST   D21S11: 29,32.2
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 8
//
RX   PubMed=11520568; DOI=10.1016/S0165-4608(01)00427-7;
RA   Chen D., Gallie B.L., Squire J.A.;
RT   "Minimal regions of chromosomal imbalance in retinoblastoma detected
RT   by comparative genomic hybridization.";
RL   Cancer Genet. Cytogenet. 129:57-63(2001).
//
RX   PubMed=15326157; DOI=10.1167/iovs.04-0140;
RA   DiCiommo D.P., Duckett A., Burcescu I., Bremner R., Gallie B.L.;
RT   "Retinoblastoma protein purification and transduction of retina and
RT   retinoblastoma cells using improved alphavirus vectors.";
RL   Invest. Ophthalmol. Vis. Sci. 45:3320-3329(2004).
//
RX   PubMed=18036396; DOI=10.1016/j.cancergencyto.2007.08.014;
RA   Paderova J., Orlic-Milacic M., Yoshimoto M., da Cunha Santos G.,
RA   Gallie B.L., Squire J.A.;
RT   "Novel 6p rearrangements and recurrent translocation breakpoints in
RT   retinoblastoma cell lines identified by spectral karyotyping and mBAND
RT   analyses.";
RL   Cancer Genet. Cytogenet. 179:102-111(2007).
//
RX   PubMed=19686387; DOI=10.1111/j.1471-4159.2009.06322.x; PMCID=PMC3726384;
RA   Glubrecht D.D., Kim J.-H., Russell L., Bamforth J.S., Godbout R.;
RT   "Differential CRX and OTX2 expression in human retina and
RT   retinoblastoma.";
RL   J. Neurochem. 111:250-263(2009).
//
RX   PubMed=23498719; DOI=10.1016/S1470-2045(13)70045-7;
RA   Rushlow D.E., Mol B.M., Kennett J.Y., Yee S., Pajovic S.,
RA   Theriault B.L., Prigoda-Lee N.L., Spencer C., Dimaras H., Corson T.W.,
RA   Pang R., Massey C., Godbout R., Jiang Z., Zacksenhaus E., Paton K.,
RA   Moll A.C., Houdayer C., Raizis A., Halliday W., Lam W.L.,
RA   Boutros P.C., Lohmann D.R., Dorsman J.C., Gallie B.L.;
RT   "Characterisation of retinoblastomas without RB1 mutations: genomic,
RT   gene expression, and clinical studies.";
RL   Lancet Oncol. 14:327-334(2013).
//
RX   PubMed=27115612; DOI=10.1371/journal.pone.0153323; PMCID=PMC4846005;
RA   Kooi I.E., Mol B.M., Massink M.P.G., de Jong M.C., de Graaf P.,
RA   van der Valk P., Meijers-Heijboer H., Kaspers G.J.L., Moll A.C.,
RA   te Riele H., Cloos J., Dorsman J.C.;
RT   "A meta-analysis of retinoblastoma copy numbers refines the list of
RT   possible driver genes involved in tumor progression.";
RL   PLoS ONE 11:e0153323.1-e0153323.20(2016).
//
RX   PubMed=32123578; DOI=10.1038/s41420-020-0237-8; PMCID=PMC7026052;
RA   Aubry A., Yu T., Bremner R.;
RT   "Preclinical studies reveal MLN4924 is a promising new retinoblastoma
RT   therapy.";
RL   Cell Death Discov. 6:2.1-2.12(2020).
//